HEK293T cells were co-transfected with the lentiviral overexpressing the envelope plasmid
pMD2.G and the packaging plasmid
pCMV∆R8.2 (both Addgene, Watertown, MA, USA) using
Fugene HD (Promega, Madison, WI, USA) and reduced medium. After 24 h, the medium was replaced with complete medium, and viral particles were harvested. After an additional 24 h, the viral particles were used to transfect A549 cells with a final concentration of 0.8 mg/mL of polybrene (Merck, TR-1003-G; Darmstadt, Germany) twice after 6 h. 0,02%
Puromycin (A1113803, Gibco) was used to select and culture the transduced A549 cells. Lentiviral constructs for miR-SCR lentiviral non-targeting control (VSC11714), and shMIMIC-miR-147b (GSH11926-213625996) were purchased from Horizon Discovery Ltd. (Cambridge, UK). The lentiviral vectors were also used for stable transfection of H838 cells. Here cells were seeded in a 6 well-plate (1 ×10
5 cells/well). For transfection, 200 µL of a transfection solution containing 1 µg plasmid, 6 µL
Fugene HD transfection reagent, and Opti-MEM reduced serum medium per well was prepared. After 24 h, the medium was changed to each cell line’s culture medium, containing 0,02%
Puromycin for selection of positive cell clones. Subsequently, the cell number was then increased under selection pressure and the cells were assayed.
Turkowski K., Herzberg F., Günther S., Weigert A., Haselbauer T., Fink L., Brunn D., Grimminger F., Seeger W., Sültmann H., Stiewe T., Pullamsetti S.S, & Savai R. (2024). miR-147b mediated suppression of DUSP8 promotes lung cancer progression. Oncogene, 43(16), 1178-1189.